Repaglinide

• UNSPSC Description:

  Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].

• Target Antigen:

  Potassium Channel

• Type:

  Reference compound

• Related Pathways:

  Membrane Transporter/Ion Channel

• Applications:

  Metabolism-sugar/lipid metabolism

• Field of Research:

  Metabolic Disease; Cancer

• Assay Protocol:

  https://www.medchemexpress.com/Repaglinide.html

• Solubility:

  DMSO : ≥ 50 mg/mL

• Smiles:

  CC(C)C[C@H](NC(CC1=CC(OCC)=C(C(O)=O)C=C1)=O)C2=CC=CC=C2N3CCCCC3

• Molecular Weight:

  452.59

• References & Citations:

  [1]Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore). 2018 Sep;97(38):e12476.

• Shipping Conditions:

  Room Temperature

• Clinical Information:

  Launched

• CAS Number:

  135062-02-1